RiaSTAP OK'd for genetic bleeding defect
Tuesday, January 20, 2009 - 14:42
in Health & Medicine
WASHINGTON, Jan. 20 (UPI) -- The U.S. Food and Drug Administration has approved RiaSTAP for the treatment of bleeding in patients with a rare genetic defect.